Cerner Corporation has announced its acquisition of life sciences company Kantar Health of Kantar Group for a cash sum of $375 million. Cerner’s focus on RWD (real world data) combined with Kantar Health’s expertise is expected to speed up drug development and to improve outcomes for patients throughout the globe.
According to Lynnette Cooke of Kantar Health, “Kantar Health and Cerner’s Strategic Growth business have a great deal in common, starting with a vision to advance patient care around the world. Culturally, we share the same values when it comes to how we develop our people, our offer and our client base. I’m excited to continue leading the team as we integrate with Cerner.” Read more here.
(Source: Cerner, 4/1/21)